SRTS Stock Financial Analysis - Sensus Healthcare, Inc. (NasdaqCM) Stock

Sensus Healthcare, Inc.
US ˙ NasdaqCM ˙ US81728J1097

Overview
Sensus Healthcare, Inc., based in the United States, operates primarily within the medical technology industry, specializing in non-invasive treatments for both oncological and non-oncological conditions. The company is renowned for its innovative approach in developing low-energy X-ray systems, particularly the SRT-100™, which is designed for superficial radiotherapy. This technology has prominently been utilized in effectively treating non-melanoma skin cancers and keloids, with a focus on enhancing patient comfort and treatment efficacy. The company’s portfolio extends to include products like the Sculptura™, which offers radiotherapy solutions specifically tailored for breast cancer, demonstrating Sensus Healthcare's commitment to advancing oncological care through targeted radiological therapies.
Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income
  • The revenue for Sensus Healthcare, Inc. as of June 30, 2025 is 37.56 MM.
  • The operating income for Sensus Healthcare, Inc. as of June 30, 2025 is -1.37 MM.
  • The net income for Sensus Healthcare, Inc. as of June 30, 2025 is -0.85 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2025-06-30 37.56 -1.37 -0.85
2025-03-31 39.49 2.56 1.80
2024-12-31 41.81 8.09 6.65
2024-09-30 41.31 11.94 9.31
2024-06-30 36.37 8.55 6.64
2024-03-31 31.65 5.44 4.65
2023-12-31 24.41 -0.38 0.48
2023-09-30 24.94 -1.79 -0.90
2023-06-30 30.06 2.27 2.38
2023-03-31 37.61 7.96 6.29
2022-12-31 44.53 14.83 24.24
2022-09-30 44.45 15.98 26.73
2022-06-30 40.97 14.01 25.10
2022-03-31 34.31 9.16 21.30
2021-12-31 27.04 4.12 4.12
2021-09-30 19.11 -0.94 -0.18
2021-06-30 15.21 -3.42 -2.07
2021-03-31 10.97 -5.71 -4.36
2020-12-31 9.58 -8.23 -6.84
2020-09-30 12.99 -7.51 -6.81
Income Statement: EPS
  • The earnings per share basic for Sensus Healthcare, Inc. as of June 30, 2025 is -0.05.
  • The earnings per share diluted for Sensus Healthcare, Inc. as of June 30, 2025 is -0.05.
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2025-06-30 -0.05 -0.05
2025-03-31 0.11 0.11
2024-12-31 0.41 0.41
2024-09-30 0.57 0.57
2024-06-30 0.41 0.41
2024-03-31 0.29 0.29
2023-12-31 0.03 0.03
2023-09-30 -0.05 -0.05
2023-06-30 0.15 0.15
2023-03-31 0.38 0.37
2022-12-31 1.47 1.46
2022-09-30 1.62 1.60
2022-06-30 1.52 1.50
2022-03-31 1.29 1.29
2021-12-31 0.25 0.25
2021-09-30 -0.01 -0.01
2021-06-30 -0.13 -0.13
2021-03-31 -0.27 -0.27
2020-12-31 -0.42 -0.42
2020-09-30 -0.42 -0.42
Cash Flow: Operations, Investing, Financing
  • The cash from operating activities for Sensus Healthcare, Inc. as of June 30, 2025 is 3.57 MM.
  • The cash from investing activities for Sensus Healthcare, Inc. as of June 30, 2025 is -0.07 MM.
  • The cash from financing activities for Sensus Healthcare, Inc. as of June 30, 2025 is -0.30 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2025-06-30 3.57 -0.07 -0.30
2025-03-31 4.68 -0.05 -0.28
2024-12-31 -0.83 -0.28 0.01
2024-09-30 2.66 -0.57 -0.02
2024-06-30 -0.85 -0.20 -0.03
2024-03-31 -4.33 -0.23 -0.05
2023-12-31 -2.15 -0.19 -0.04
2023-09-30 -14.93 -0.20 -1.97
2023-06-30 -11.64 -0.29 -1.72
2023-03-31 -10.49 -0.30 -2.69
2022-12-31 -1.41 14.84 -2.43
2022-09-30 6.92 14.81 -0.55
2022-06-30 4.45 14.87 -0.82
2022-03-31 3.91 15.16 0.10
2021-12-31 -0.29 0.13 -0.23
2021-09-30 1.13 0.06 -0.93
2021-06-30 -2.76 0.42 -0.87
2021-03-31 -1.98 3.38 0.15
2020-12-31 -0.43 7.03 0.21
2020-09-30 0.39 7.87 0.97
Valuation Metrics : PE, PriceToBook, PriceToTBV
  • The p/book for Sensus Healthcare, Inc. as of June 30, 2025 is 1.47.
  • The p/tbv for Sensus Healthcare, Inc. as of June 30, 2025 is 1.47.
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2025-06-30 1.47 1.47
2025-03-31 1.41
2024-12-31 2.17 2.17
2024-09-30 14.50 1.82 1.82
2024-06-30 18.71 1.70 1.70
2024-03-31 132.51 1.32
2023-12-31 -43.70 0.88 0.88
2023-09-30 18.98 0.98 0.98
2023-06-30 8.55 1.16 1.16
2023-03-31 3.53 1.78
2022-12-31 2.63 2.63
2022-09-30 4.61 4.62
2022-06-30 3.00 3.01
2022-03-31 40.72 6.45 6.48
2021-12-31 -662.29 5.80 5.85
2021-09-30 -28.92 2.96 2.99
2021-06-30
2021-03-31 -27.59 5.89 5.98
2020-12-31 -17.61 5.60 5.69
2020-09-30 -17.68 5.90 6.01
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
  • The ebit/ev for Sensus Healthcare, Inc. as of June 30, 2025 is 0.06.
  • The ebit (3y)/ev for Sensus Healthcare, Inc. as of June 30, 2025 is 0.09.
Period End (TTM) EBIT/EV EBIT (3y)/EV
2025-06-30 0.06 0.09
2025-03-31 0.16 0.14
2024-12-31 0.14 0.15
2024-09-30 0.12 0.16
2024-06-30 0.09 0.17
2024-03-31 0.02 0.27
2023-12-31 -0.04 0.50
2023-09-30 0.12 0.37
2023-06-30 0.25 0.32
2023-03-31 0.47 0.25
2022-12-31 0.34 0.08
2022-09-30 0.15 0.04
2022-06-30 0.23 0.05
2022-03-31 0.03 -0.01
2021-12-31 -0.00 -0.03
2021-09-30 -0.05 -0.09
2021-06-30
2021-03-31 -0.04 -0.03
2020-12-31 -0.06 -0.03
2020-09-30 -0.06 -0.04
Management Effectiveness
  • The roa for Sensus Healthcare, Inc. as of June 30, 2025 is 0.03.
  • The roe for Sensus Healthcare, Inc. as of June 30, 2025 is 0.03.
  • The roic for Sensus Healthcare, Inc. as of June 30, 2025 is 0.03.
  • The croic for Sensus Healthcare, Inc. as of June 30, 2025 is 0.08.
  • The ocroic for Sensus Healthcare, Inc. as of June 30, 2025 is 0.09.
Period End (TTM) ROA ROE ROIC CROIC OCROIC
2025-06-30 0.03 0.03 0.03 0.08 0.09
2025-03-31 0.12 0.13 0.12 -0.02 -0.01
2024-12-31 0.17 0.19 0.17 0.04 0.05
2024-09-30 0.13 0.15 0.12 -0.02 -0.02
2024-06-30 0.09 0.10 0.09 -0.09 -0.08
2024-03-31 0.01 0.01 0.01 -0.05 -0.04
2023-12-31 -0.02 -0.02 -0.02 -0.38 -0.33
2023-09-30 0.04 0.05 0.05 -0.29 -0.25
2023-06-30 0.11 0.14 0.05 -0.29 -0.25
2023-03-31 0.45 0.57 0.13 -0.29 -0.22
2022-12-31 1.04 1.30 0.55 0.44 0.14
2022-09-30 0.98 1.22 0.55 0.44 0.14
2022-06-30 0.81 1.05 0.54 0.40 0.10
2022-03-31 0.16 0.20 0.49 0.44 0.09
2021-12-31 -0.01 -0.01 0.15 -0.01 0.05
2021-09-30 -0.01 -0.10 -0.01 0.01 -0.13
2021-06-30 -0.07 -0.09 -0.10 -0.15 -0.13
2021-03-31 -0.13 -0.18 -0.20 0.07 -0.09
2020-12-31 -0.19 -0.24 -0.30 0.30 -0.02
2020-09-30 -0.19 -0.25 -0.30 0.41 0.02
Gross Margins
  • The gross margin for Sensus Healthcare, Inc. as of June 30, 2025 is 0.56.
  • The net margin for Sensus Healthcare, Inc. as of June 30, 2025 is 0.05.
  • The operating margin for Sensus Healthcare, Inc. as of June 30, 2025 is 0.06.
Gross Margin
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Net Margin
The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
Operating Margin
The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) Gross Margin Net Margin Operating Margin
2025-06-30 0.56 0.05 0.06
2025-03-31 0.58 0.16 0.19
2024-12-31 0.61 0.23 0.29
2024-09-30 0.60 0.18 0.24
2024-06-30 0.60 0.15 0.17
2024-03-31 0.58 0.02 -0.02
2023-12-31 0.58 -0.04 -0.07
2023-09-30 0.61 0.08 0.08
2023-06-30 0.64 0.08 0.08
2023-03-31 0.67 0.17 0.21
2022-12-31 0.68 0.60 0.36
2022-09-30 0.67 0.60 0.36
2022-06-30 0.66 0.61 0.34
2022-03-31 0.63 0.62 0.27
2021-12-31 0.59 0.15 0.15
2021-09-30 0.58 -0.01 -0.05
2021-06-30 0.58 -0.14 -0.22
2021-03-31 0.56 -0.40 -0.52
2020-12-31 0.55 -0.71 -0.86
2020-09-30 0.58 -0.52 -0.58
Identifiers and Descriptors
Central Index Key (CIK)1494891
Other Listings
DE:5TX €2.74
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista